ChronoScale Corporation Common Stock (NASDAQ:CHRN) Issues Quarterly Earnings Results

ChronoScale Corporation Common Stock (NASDAQ:CHRN) announced its earnings results on Tuesday. The company reported ($3.89) earnings per share for the quarter, FiscalAI reports. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%.The company had revenue of $18.09 million during the quarter.

ChronoScale Corporation Common Stock Stock Performance

Shares of CHRN opened at $17.64 on Thursday. ChronoScale Corporation Common Stock has a 12 month low of $2.91 and a 12 month high of $28.20. The firm has a fifty day simple moving average of $17.21 and a 200 day simple moving average of $12.03. The stock has a market capitalization of $62.85 million, a price-to-earnings ratio of -3.28 and a beta of 0.99. The company has a current ratio of 1.55, a quick ratio of 1.03 and a debt-to-equity ratio of 0.25.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of ChronoScale Corporation Common Stock in a report on Friday, March 27th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, ChronoScale Corporation Common Stock has an average rating of “Reduce” and an average price target of $6.00.

Hedge Funds Weigh In On ChronoScale Corporation Common Stock

A number of large investors have recently modified their holdings of the business. Consolidated Portfolio Review Corp acquired a new stake in shares of ChronoScale Corporation Common Stock in the third quarter valued at about $333,000. Shay Capital LLC bought a new stake in shares of ChronoScale Corporation Common Stock during the 3rd quarter worth approximately $67,000. Virtu Financial LLC acquired a new stake in shares of ChronoScale Corporation Common Stock in the 3rd quarter valued at approximately $57,000. Citadel Advisors LLC bought a new position in shares of ChronoScale Corporation Common Stock in the third quarter valued at $198,000. Finally, Geode Capital Management LLC increased its holdings in ChronoScale Corporation Common Stock by 68.9% during the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after buying an additional 10,281 shares during the last quarter. 6.42% of the stock is currently owned by institutional investors and hedge funds.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.